Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109651

Activation of Rabbit Hageman Factor by Homogenates of Cultured Rabbit Endothelial Cells

Roger C. Wiggins, David J. Loskutoff, Charles G. Cochrane, John H. Griffin, and Thomas S. Edgington

Department of Immunopathology, Research Institute of Scripps Clinic, La Jolla, California 92037

Department of Molecular Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037

Find articles by Wiggins, R. in: PubMed | Google Scholar

Department of Immunopathology, Research Institute of Scripps Clinic, La Jolla, California 92037

Department of Molecular Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037

Find articles by Loskutoff, D. in: PubMed | Google Scholar

Department of Immunopathology, Research Institute of Scripps Clinic, La Jolla, California 92037

Department of Molecular Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037

Find articles by Cochrane, C. in: PubMed | Google Scholar

Department of Immunopathology, Research Institute of Scripps Clinic, La Jolla, California 92037

Department of Molecular Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037

Find articles by Griffin, J. in: PubMed | Google Scholar

Department of Immunopathology, Research Institute of Scripps Clinic, La Jolla, California 92037

Department of Molecular Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037

Find articles by Edgington, T. in: PubMed | Google Scholar

Published January 1, 1980 - More info

Published in Volume 65, Issue 1 on January 1, 1980
J Clin Invest. 1980;65(1):197–206. https://doi.org/10.1172/JCI109651.
© 1980 The American Society for Clinical Investigation
Published January 1, 1980 - Version history
View PDF
Abstract

Rabbit Hageman factor was proteolytically cleaved and activated by a homogenate prepared from cultured rabbit endothelial cells. Cleavage of radiolabeled Hageman factor was monitored by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. Endothelial cell-mediated cleavage of Hageman factor was demonstrated both in a purified system and in plasma, was time and concentration dependent, and was associated with formation of the characteristic 28,000 Mr form of active Hageman factor. The rate of cleavage of Hageman factor was not affected by Triton X-100 (Rohm and Haas, Co., Philadelphia, Pa.), hexadimethrine bromide (Polybrene, Aldrich Chemical Co., Inc., Milwaukee, Wis.), hirudin, soybean trypsin inhibitor, or antisera to plasminogen or prekallikrein. However, cleavage was enhanced by kaolin, and was inhibited by diisopropyl-fluorophosphate. The enzyme responsible for cleavage of Hageman factor was localized to the 100,000-g-sedimentable, subcellular fraction of the endothelial cell homogenate and was relatively specific, because neither radiolabeled rabbit Factor XI nor rabbit prekallikrein were themselves proteolytically cleaved by the endothelial cell homogenate. However, when these molecules were incubated with the homogenate in the presence of Hageman factor, both Factor XI and prekallikrein were cleaved, demonstrating that Hageman factor had been activated by the endothelial cell homogenate. Furthermore, the kallikrein generated by endothelial cell homogenate-activated Hageman factor was capable of liberating kinin from high molecular weight kininogen as measured by bioassay. Cultured rabbit endothelial cells, therefore, possess the capacity to activate Hageman factor by proteolysis. This may be one mechanism for Hageman factor activation in vivo.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 197
page 197
icon of scanned page 198
page 198
icon of scanned page 199
page 199
icon of scanned page 200
page 200
icon of scanned page 201
page 201
icon of scanned page 202
page 202
icon of scanned page 203
page 203
icon of scanned page 204
page 204
icon of scanned page 205
page 205
icon of scanned page 206
page 206
Version history
  • Version 1 (January 1, 1980): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts